[Federal Register Volume 61, Number 65 (Wednesday, April 3, 1996)]
[Notices]
[Pages 14801-14802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8154]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Heart, Lung, and Blood Institute; Notice of as Closed 
Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, a 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart, Lung, and Blood Special Emphasis Panel (SEP) meeting:

    Name of SEP: Folow-up Analysis of Biologic Samples from the 
Ibuprofen Trial (Telephone Conference Call).
    Date: April 25, 1996.
    Time: 1:00 p.m.
    Place: 6701 Rockledge Drive, Room 7220, Bethesda, Maryland 
20892.
    Contact Person: C. James Scheirer, Ph.D,, 6701 Rockledge Drive, 
Room 7220, Bethesda, Maryland 20892-7220, (301) 435-0266.
    Purpose/Agenda: To review and evaluate a contract proposal.

    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the applications 
and/or proposals, the

[[Page 14802]]
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: March 28, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-8154 Filed 4-2-96; 8:45 am]
BILLING CODE 4140-01-M